Evidence map›Paper›PMID 34457119›Full record

ReviewOxidative medicine and cellular longevity2021

Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets.

Adriana Fodor, Brandusa Tiperciuc, Cezar Login, Olga H Orasan, Andrada L Lazar, Cristina Buchman, Patricia Hanghicel, Adela Sitar-Taut, Ramona Suharoschi, Romana Vulturar and 1 more

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. FermentedNutrients · 2022
    Trial
  3. Microvascular Dysfunction and Redox Imbalance in Long COVID.Microcirculation (New York, N.Y. : 1994) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. VEGF Polymorphisms (International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Adriana FodorClinical Center of Diabetes, Nutrition, and Metabolic Diseases, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, CJ, Romania.ORCID https://orcid.org/0000-0002-1124-6984
Brandusa TiperciucDepartment of Pharmaceutical Chemistry, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.ORCID https://orcid.org/0000-0002-1333-5649
Cezar LoginDepartment of Physiology, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, CJ, Romania.ORCID https://orcid.org/0000-0003-4690-3259
Olga H OrasanInternal Medicine Department, 4th Medical Clinic "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.ORCID https://orcid.org/0000-0003-4435-142X
Andrada L LazarDepartment of Dermatology, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.ORCID https://orcid.org/0000-0001-8428-8088
Cristina BuchmanDepartment of Oncology, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400015 Cluj-Napoca, Romania.ORCID https://orcid.org/0000-0001-5926-1721
Patricia HanghicelDepartment of Neurology, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.ORCID https://orcid.org/0000-0001-8252-1456
Adela Sitar-TautInternal Medicine Department, 4th Medical Clinic "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.ORCID https://orcid.org/0000-0001-8590-4583
Ramona SuharoschiDepartment of Food Science, University of Agricultural Science and Veterinary Medicine, 400372 Cluj-Napoca, Romania.ORCID https://orcid.org/0000-0002-8306-8670
Romana VulturarDepartment of Molecular Sciences, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.ORCID https://orcid.org/0000-0003-2476-9706
Angela CozmaInternal Medicine Department, 4th Medical Clinic "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.ORCID https://orcid.org/0000-0002-3989-2291
Iuliu Hațieganu University of Medicine and Pharmacy · ROUniversity of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The outbreak of the COVID-19 pandemic represents an ongoing healthcare emergency responsible for more than 3.4 million deaths worldwide. COVID-19 is the disease caused by SARS-CoV-2, a virus that targets not only the lungs but also the cardiovascular system. COVID-19 can manifest with a wide range of clinical manifestations, from mild symptoms to severe forms of the disease, characterized by respiratory failure due to severe alveolar damage. Several studies investigated the underlying mechanisms of the severe lung damage associated with SARS-CoV-2 infection and revealed that the respiratory failure associated with COVID-19 is the consequence not only of acute respiratory distress syndrome but also of macro- and microvascular involvement. New observations show that COVID-19 is an endothelial disease, and the consequent endotheliopathy is responsible for inflammation, cytokine storm, oxidative stress, and coagulopathy. In this review, we show the central role of endothelial dysfunction, inflammation, and oxidative stress in the COVID-19 pathogenesis and present the therapeutic targets deriving from this endotheliopathy.

Indexed as

Oxidative StressCOVID-19Cytokine Release SyndromeEndothelium, VascularHumansInflammationSARS-CoV-2Vascular Diseases

Identifiers

PMID34457119
PMCPMC8397545
OpenAlexW3194838995

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.